Cholinergic markers in degenerative parkinsonism: autoradiographic demonstration of high-affinity choline uptake carrier hyperactivity

[1]  H. Happe,et al.  High‐Affinity Choline Transport Sites: Use of [3H]Hemicholinium‐3 as a Quantitative Marker , 1993, Journal of neurochemistry.

[2]  J. Joyce.  Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. III. Results in Parkinson's disease cases , 1993, Brain Research.

[3]  C D Marsden,et al.  Altered Muscarinic and Nicotinic Receptor Densities in Cortical and Subcortical Brain Regions in Parkinson's Disease , 1993, Journal of neurochemistry.

[4]  S. Gauthier,et al.  Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's Diseases , 1992, Journal of neurochemistry.

[5]  R. Quirion,et al.  Heterogeneous binding of [3H]4‐DAMP to muscarinic cholinergic sites in the rat brain: Evidence from membrane binding and autoradiographic studies , 1991, Synapse.

[6]  S. Carmichael,et al.  Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients , 1991, Annals of neurology.

[7]  Á. Pazos,et al.  High-affinity choline uptake carrier in Alzheimer's disease: implications for the cholinergic hypothesis of dementia , 1991, Brain Research.

[8]  Á. Pazos,et al.  Characterization of [3H]Hemicholinium‐3 Binding Sites in Human Brain Membranes: A Marker for Presynaptic Cholinergic Nerve Terminals , 1990, Journal of neurochemistry.

[9]  Á. Pazos,et al.  Autoradiographic distribution of [3H]hemicholinium-3 binding sites in human brain , 1989, Brain Research.

[10]  J. Rinne,et al.  Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease , 1989, Brain Research.

[11]  J. Rinne,et al.  Different forms of brain acetylcholinesterase and muscarinic binding in Parkinson's disease , 1989, Journal of the Neurological Sciences.

[12]  D. Mash,et al.  Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. , 1985, Science.

[13]  E. Perry,et al.  Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[14]  S Tucek,et al.  Regulation of Acetylcholine Synthesis in the Brain , 1985, Journal of neurochemistry.

[15]  J. Palacios,et al.  Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: Brainstem , 1984, Neuroscience.

[16]  M. Modan,et al.  Effects of anticholinergic drugs on memory in Parkinson's disease. , 1982, Archives of neurology.

[17]  Michael J. Kuhar,et al.  Quantitative receptor autoradiography using [3H]Ultrofilm: application to multiple benzodiazepine receptors , 1982, Journal of Neuroscience Methods.

[18]  Y. Agid,et al.  Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia , 1982, Brain Research.

[19]  I. Nakano,et al.  Parhnson’s Disease: Neuron Loss in the Nucleus Basah Without Concomitant Alzheimer’s Disease , 2004 .

[20]  J. Zubieta,et al.  Autoradiographic mapping of M3 muscarinic receptors in the rat brain. , 1993, The Journal of pharmacology and experimental therapeutics.

[21]  E. Perry,et al.  Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types , 1990, Journal of neural transmission. Parkinson's disease and dementia section.